# NARCAN NALOXONE HCI

NDC: 51662-1240
Generic name: NARCAN NALOXONE HCI
Labeler / Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SPRAY
Routes: NASAL
Marketing started: 20181015

FDA application: NDA208411

## Active ingredients

- NALOXONE HYDROCHLORIDE: 4 mg/.1mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51662-1240"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51662-1240
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=784a0e98-c2d6-f845-e053-2991aa0ac4b4